Literature DB >> 10208218

Emerging therapies for cystic fibrosis lung disease.

B K Rubin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10208218     DOI： 10.1378/chest.115.4.1120

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

1.  Canine adenovirus vectors for lung-directed gene transfer: efficacy, immune response, and duration of transgene expression using helper-dependent vectors.

Authors:  Anne Keriel; Céline René; Chad Galer; Joseph Zabner; Eric J Kremer
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery.

Authors:  Guihong Chai; Amr Hassan; Tuo Meng; Lihua Lou; Jonathan Ma; Russell Simmers; Lei Zhou; Bruce K Rubin; Qi Tony Zhou; P Worth Longest; Michael Hindle; Qingguo Xu
Journal:  Nanomedicine       Date:  2020-07-03       Impact factor: 5.307

3.  Home IV Antibiotic Therapy and Exercise Capacity in Children with CF: A Case Series.

Authors:  Narelle S Cox; Karen O McKay; Jennifer M Follett; Jennifer A Alison
Journal:  Cardiopulm Phys Ther J       Date:  2011-03

Review 4.  Active cycle of breathing technique for cystic fibrosis.

Authors:  Naomi A Mckoy; Lisa M Wilson; Ian J Saldanha; Olaide A Odelola; Karen A Robinson
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.